Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.

AusPAR: Emtricitabine / Tenofovir alafenamide (as fumarate)

Australian Public Assessment Report

AusPAR

AusPAR: Emtricitabine / Tenofovir alafenamide (as fumarate) [PDF, 1.36 MB]

AusPAR: Emtricitabine / Tenofovir alafenamide (as fumarate) [DOCX, 1.29 MB]

Attachment: Product Information: Emtricitabine / Tenofovir alafenamide (as fumarate) [PDF, 453.83 KB]

Attachment: Product Information: Emtricitabine / Tenofovir alafenamide (as fumarate) [DOCX, 154.73 KB]

Attachment: Extract from Clinical Evaluation Report: Emtricitabine / Tenofovir alafenamide (as fumarate) [PDF, 2.42 MB]

Attachment: Extract from Clinical Evaluation Report: Emtricitabine / Tenofovir alafenamide (as fumarate) [DOCX, 2.58 MB]

Device/Product Name

Descovy

Active ingredients

Emtricitabine / Tenofovir alafenamide (as fumarate)

AusPAR Date

20 December 2016

Published

23 December 2016

Submission Number

PM-2015-01283-1-3

Submission Type

New fixed dose combination

Decision

Approved

Product types

Prescription medicines